Health in countries torn by conflict: lessons from Sarajevo

M. Carballo,S. Simic,D. Zeric

DOI: https://doi.org/10.1016/S0140-6736(96)05386-X

IF: 202.731

1996-09-28

The Lancet

Abstract:

What problem does this paper attempt to address?

Preliminary report on the Mount Sinai Hospital Inflammatory Bowel Disease Genetics Project

Rima McLeod,AH Steinhart,Kathy Siminovitch,Gordon R. Greenberg,Shelley B. Bull,JE Blair,C. Cruz,P. Barton,Zane Cohen

DOI: https://doi.org/10.1007/BF02055377

1997-05-01

Diseases of the Colon & Rectum

Abstract:
Oxygen-Generating Scaffolds: One Step Closer to the Clinical Translation of Tissue Engineered Products

Robin Augustine,Mert Gezek,Nazli Seray Bostanci,Angelina Nguyen,Gulden Camci-Unal

DOI: https://doi.org/10.1016/j.cej.2022.140783

2023-01-01

Abstract:The lack of oxygen supply in engineered constructs has been an ongoing challenge for tissue engineering and regenerative medicine. Upon implantation of an engineered tissue, spontaneous blood vessel formation does not happen rapidly, therefore, there is typically a limited availability of oxygen in engineered biomaterials. Providing oxygen in large tissue-engineered constructs is a major challenge that hinders the development of clinically relevant engineered tissues. Similarly, maintaining adequate oxygen levels in cell-laden tissue engineered products during transportation and storage is another hurdle. There is an unmet demand for functional scaffolds that could actively produce and deliver oxygen, attainable by incorporating oxygen-generating materials. Recent approaches include encapsulation of oxygen-generating agents such as solid peroxides, liquid peroxides, and fluorinated substances in the scaffolds. Recent approaches to mitigate the adverse effects, as well as achieving a sustained and controlled release of oxygen, are discussed. Importance of oxygen-generating materials in various tissue engineering approaches such as ex vivo tissue engineering, in situ tissue engineering, and bioprinting are highlighted in detail. In addition, the existing challenges, possible solutions, and future strategies that aim to design clinically relevant multifunctional oxygen-generating biomaterials are provided in this review paper.
Computer-based ophthalmotropes.

R. Clement

Abstract:The versatility of a computer-based display of the extraocular muscles is demonstrated by comparing two different assumptions as to the paths of the muscles over the globe.
pO2 reporter composite hydrogel macroencapsulation devices for magnetic resonance imaging oxygen quantification

Amy E. Emerson,Yuka Sugamura,Jad Mazboudi,Tuhfah M. Abdallah,Charmayne D. Seaton,Azin Ghasemi,Vikram D. Kodibagkar,Jessica D. Weaver

DOI: https://doi.org/10.1002/jbm.a.37707

2024-03-17

Journal of Biomedical Materials Research Part A

Abstract:Hydrogel cell encapsulation devices are a common approach to reduce the need for chronic systemic immunosuppression in allogeneic cell product transplantation. Macroencapsulation approaches are an appealing strategy, as they maximize graft retrievability and cell dosage within a single device; however, macroencapsulation devices face oxygen transport challenges as geometries increase from preclinical to clinical scales. Device design guided by computational approaches can facilitate graft oxygen availability to encapsulated cells in vivo but is limited without accurate measurement of oxygen levels within the transplant site and graft. In this study, we engineer pO2 reporter composite hydrogels (PORCH) to enable spatiotemporal measurement of oxygen tension within macroencapsulation devices using the proton Imaging of siloxanes to map tissue oxygenation levels (PISTOL) magnetic resonance imaging approach. We engineer two methods of incorporating siloxane oximetry reporters within hydrogel devices, an emulsion and microbead‐based approach, and evaluate PORCH cytotoxicity on co‐encapsulated cells and accuracy in quantifying oxygen tension in vitro. We find that both emulsion and microbead PORCH approaches enable accurate in situ oxygen quantification using PISTOL magnetic resonance oximetry, and that the emulsion‐based PORCH approach results in higher spatial resolution.

engineering, biomedical,materials science, biomaterials
Oxygen-Enriched Osteoinductive Nanoerythrocytes Augment Cell Survival and Osteogenic Differentiation for Bone Regeneration

Chung-Sung Lee,Jiabing Fan,Hee Sook Hwang,Chen Chen,Soyon Kim,Tara Aghaloo,Min Lee

DOI: https://doi.org/10.1021/acs.chemmater.2c00376

IF: 10.508

2022-06-27

Chemistry of Materials

Abstract:Despite three-dimensional biomaterial scaffolds emerging for facilitating tissue remodeling and recovery in tissue engineering, the scaffolds with an insufficient oxygen supply are limited by various concerns, such as their retention, localization, survival, and lineage fate control of post-transplantation of stem cells. Herein, we report oxygen-enriched osteoinductive nanoerythrocytes as a facile biomimetic platform for bone formation, combining the biocompatibility of natural red blood cell membranes with the oxygen-carrying perfluorocarbons and the osteoinductive oxysterols. The resulting nanoerythrocytes exhibit a high capacity for oxygen delivery, improving cell survival and proliferation and mitigating hypoxic stress in cell-laden hydrogels as a three-dimensional biomaterial device in vitro and in vivo. Notably, the introduction of oxysterols incites the osteoinductive activity for the differentiation of progenitor cells toward osteogenic lineage through the positive regulation of Hedgehog signaling and in vivo reossification activity against a nonhealing calvarial defect. Given the beneficial properties of the assembled parts in a facile single system, this bioactive and biomimetic nanodelivery system can have the potential to address desired needs in the biomaterial scaffolds for cell delivery and bone tissue engineering.

materials science, multidisciplinary,chemistry, physical
Astringent Mouthfeel as a Consequence of Lubrication Failure.

Shuanhong Ma,Haeshin Lee,Yongmin Liang,Feng Zhou

DOI: https://doi.org/10.1002/anie.201601667

2016-05-04

Angewandte Chemie

Abstract:Herein, we systematically investigate the origin of astringent mouthfeel when we eat unripe fruits, drink coffee or tea, from the perspective of lubrication by simulating the dynamic weak interaction on the tongue with model protein (mucoprotein, MP) and polyphenolic compounds (tannic acid, TA). Astringency was due to the protein-mediated lubrication failure when encountering polyphenolic molecules that normally exist, for example in unripe fruits, coffee, tea. The underlying molecular mechanism of oral tribology is widely present in nature and enables us to engineer a tongue-like polyacrylamide composite hydrogel that exhibits high TA sensitivity and to develop a scientific strategy for catching slippery fish using TA-containing gloves. These results provide novel and useful insights into the failure of biological boundary lubrication on soft tissue surface with the adsorbed proteins.
Plastic surgery at the turn of the century: an opportunity for self-assessment.

J. McCarthy

DOI: https://doi.org/10.1097/00006534-200003000-00062

2000-03-01

Abstract:As we enter the 21st century, the year 2000, or Y2K, what are some of the issues that we, as plastic surgeons, will face? We all know that change is life’s one constant but that change also presents opportunities. We should also recognize that change has positive and negative aspects. As Sir Francis Bacon said: “He who will not apply new remedies must expect new evils.” That said, I want to examine several issues of critical importance, as I see it, to plastic surgery today. First, I want to look at their positive as well as negative aspects. Then I would like to make specific recommendations—courses of action that to me seem to be essential to our future growth and success. Change is not coming; change is here now. And like all Darwin’s creatures, we will have to adapt smartly if we intend to survive. First, I think we all would agree that the loss or diminution of physician autonomy has had a tremendous impact on our lives and our profession. I know that in my case one of the strong incentives for pursuing a career in medicine was that one day I could “hang out my shingle” and direct the course of my professional career. I think that for many of us the dream was to study, learn, and go forth to treat patients. Today, young plastic surgeons, just completing residency training and saddled with educational loans, have little chance of “hanging out their shingles.” There are fewer practice opportunities; start-up costs are enormous and the system of reimbursement changes daily. I began by writing that we had to look at both sides of every issue. One could, in fact, argue eloquently that the lack of physician autonomy has a brighter side than the one I just described. Anyone who has ever run his or her own practice knows well the meaning of the phrase “you don’t own a small business; it owns you.” Giving up what we might call such “indentured autonomy” generally means getting out from under a mountain of tedious detail, allowing you to spend more time with your patients— and losing autonomy can probably be good for your health. But to me and my generation of physicians, the concept of “shift medicine” was looked down upon. Obstetricians would never think of leaving a woman in labor just because their shift was up. Normal schedules were something only for “regular” human beings. Recently we have come to realize that physicians are regular human beings—that they work more effectively if they can get off the treadmill once in a while—that creative insight is often the product of rest and time away from the practice. And, in this sense, shift medicine may actually lead to a higher quality practice of medicine. But turn the coin over again—I do not want someone in my family to be the woman in active labor when the doctor announces, “Shift over, see you tomorrow. Meet Doctor X and the next crew.” Nor would I particularly like to be the patient of a group practice that, to survive economically, must restrict time with each patient to 12 minutes. But such are the economics of reduced physician autonomy. Reduced physician autonomy has other negative effects. It stifles surgical education programs. The enthusiastic surgery resident, who
Microfluidic strategies for engineering oxygen-releasing biomaterials

Zhiqiang Zhu,Tianao Chen,Yongqi Wu,Xizhi Wu,Zhongliang Lang,Fangsheng Huang,Pingan Zhu,Ting Si,Ronald X Xu

DOI: https://doi.org/10.1016/j.actbio.2024.03.032

2024-04-15

Abstract:In the field of tissue engineering, local hypoxia in large-cell structures (larger than 1 mm3) poses a significant challenge. Oxygen-releasing biomaterials supply an innovative solution through oxygen ⁠ delivery in a sustained and controlled manner. Compared to traditional methods such as emulsion, sonication, and agitation, microfluidic technology offers distinct benefits for oxygen-releasing material production, including controllability, flexibility, and applicability. It holds enormous potential in the production of smart oxygen-releasing materials. This review comprehensively covers the fabrication and application of microfluidic-enabled oxygen-releasing biomaterials. To begin with, the physical mechanism of various microfluidic technologies and their differences in oxygen carrier preparation are explained. Then, the distinctions among diverse oxygen-releasing components in regards for oxygen-releasing mechanism, oxygen-carrying capacity, and duration of oxygen release are presented. Finally, the present obstacles and anticipated development trends are examined together with the application outcomes of oxygen-releasing biomaterials based on microfluidic technology in the biomedical area. STATEMENT OF SIGNIFICANCE: Oxygen is essential for sustaining life, and hypoxia (a condition of low oxygen) is a significant challenge in various diseases. Microfluidic-based oxygen-releasing biomaterials offer precise control and outstanding performance, providing unique advantages over traditional approaches for tissue engineering. However, comprehensive reviews on this topic are currently lacking. In this review, we provide a comprehensive analysis of various microfluidic technologies and their applications for developing oxygen-releasing biomaterials. We compare the characteristics of organic and inorganic oxygen-releasing biomaterials and highlight the latest advancements in microfluidic-enabled oxygen-releasing biomaterials for tissue engineering, wound healing, and drug delivery. This review may hold the potential to make a significant contribution to the field, with a profound impact on the scientific community.
Implantable Multifunctional Micro‐Oxygen Reservoir System for Promoting Vascular‐Osteogenesis via Remodeling Regenerative Microenvironment

Min Rui,Jiannan Mao,Hongshuai Wu,Yujian Hui,Hao Shen,Yilin Yang,Tao Ma,Kewei Ren,Juan Wang,Wenguo Cui,Qin Shi,Huilin Yang

DOI: https://doi.org/10.1002/advs.202409636

IF: 15.1

2024-11-28

Advanced Science

Abstract:An oxygenating hydrogel microsphere (CSP‐GM) integrated with CSP nanoparticles is developed as a multifaceted microenvironment regulator. This innovative system effectively remodels the regenerative microenvironment by synergistically producing oxygen and scavenging ROS, recovering mitochondrial homeostasis and antioxidant defenses of BMSCs, promoting angiogenesis and osteogenesis under hypoxia conditions via precisely modulating the Nrf2/HO‐1 signaling pathways, thereby facilitating bone regeneration. Hypoxia and reactive oxygen species (ROS) overaccumulation cause persistent oxidative stress and impair intrinsic regenerative potential upon tissue injury. For local tissue injury with hypoxia, such as bone fracture and defects, a localized‐sufficient oxygen supply is highly desirable but remains challenging. Therefore, to explore a strategy and its intrinsic mechanism for supplying oxygen locally and remodeling the regenerative microenvironment, an innovative oxygenating hydrogel microsphere system with sustained oxygenation and antioxidant properties is introduced by loading CaO2@SiO2@PDA (CSP) nanoparticles. Specifically, the CSP nanoparticles exhibited broad‐spectrum free radicals scavenging ability, along with prolonged controlled‐release of oxygen once integrated into the gelatin methacrylate anhydride (GelMA) microspheres (CSP‐GM). The CSP‐GM with extra cellular matrix (ECM)‐mimicking structures reconstructed living niches, promoting the adhesion and proliferation of bone marrow stromal cells (BMSCs). As a multifaceted microenvironment regulator, CSP‐GM remodeled the regenerative microenvironment by synergistically producing oxygen and scavenging ROS, recovering mitochondrial homeostasis and antioxidant defenses of BMSCs, promoting angiogenesis and osteogenesis under hypoxia conditions via precisely modulating the Nrf2/HO‐1 signaling pathway. The multiple pro‐regenerative effects of the implantable functionalized micro‐oxygen reservoir on bone repair are further corroborated by the enhanced vascularized bone formation in rat femoral defects, presenting a comprehensive and promising strategy for tissue repair.

materials science, multidisciplinary,nanoscience & nanotechnology,chemistry
Oxygenating respiratoid biosystem for therapeutic cell transplantation

Seonmi Jang,Chaerim Yoo,Hyung Shik Kim,Jiyun Kim,Dong Yun Lee

DOI: https://doi.org/10.1038/s41467-024-53246-w

2024-10-23

Abstract:In this study, we address the persistent challenge of providing adequate oxygen to transplanted cells by introducing a respiratoid biosystem. Central to our strategy is the chloroplast-transit-peptide (CTP), crucial for optimal oxygenation. Through conjugation of CTP with alginate, we achieve stabilization of chloroplast structure. Strategically anchored to the outer chloroplast membrane, CTP not only ensures structural integrity but also upregulates key photosynthesis-associated genes. This biosystem demonstrates exceptional efficacy in spontaneously generating oxygen, particularly under hypoxic conditions (~1% pO2). In an application, pancreatic islets encapsulated within the respiratoid biosystem and intraperitoneally implanted in diabetic mice maintain normal glucose levels effectively. Insulin secretion persists for 100 days post-xenotransplantation without the need for immunosuppressant administration, highlighting the reliance on the respiratoid biosystem's oxygen supply and structural stability. Our study demonstrates the respiratoid biosystem as a platform in tissue engineering, offering a nature-inspired solution to the critical challenge of spontaneous oxygen supply.
Fabrication of oxygen-releasing dextran microgels by droplet-based microfluidic method

Daisuke Tomioka,Shannon Anna Jung,Andrij Pich,Michiya Matsusaki

DOI: https://doi.org/10.1039/d4ra04356a

2024-08-22

Abstract:In the tissue engineering field, the supply of oxygen to three-dimensional (3D) tissues is an important aspect to avoid necrosis due to hypoxia. Although oxygen-releasing bulk materials containing calcium peroxide (CaO2, CP) have attracted much attention, micrometer-sized oxygen-releasing soft materials would be advantageous because of their highly controllable structures, which can be applied for cell scaffolds, injectable materials, and bioink components in 3D bioprinting. In this study, oxygen-releasing microgels were fabricated via a droplet-based microfluidic system. Homogeneous, monodisperse and stable oxygen-releasing microgels were obtained by photo-crosslinking of droplets composed of biocompatible dextran modified with methacrylate groups and CP nanoparticles as an oxygen source. We also used our microfluidic system for the in situ amorphous calcium carbonate (CaCO3, ACC) formation on the surface of CP nanoparticles to achieve the controlled release of oxygen from the microgel. Oxygen release from an ACC-CP microgel in a neutral cell culture medium was suppressed because incorporation of CP in the ACC suppressed the reaction with water. Strikingly, stimuli to dissolve ACC such as a weak acidic conditions triggered the oxygen release from microgels loaded with ACC-CP, as the dissolution of CaCO3 allows CP to react. Taken together, applications of this new class of biomaterials for tissue engineering are greatly anticipated. In addition, the developed microfluidic system can be used for a variety of oxygen-releasing microgels by changing the substrates of the hydrogel network.
3D-printed oxygen-releasing scaffolds improve bone regeneration in mice

Ashley L Farris,Dennis Lambrechts,Yuxiao Zhou,Nicholas Y Zhang,Naboneeta Sarkar,Megan C Moorer,Alexandra N Rindone,Ethan L Nyberg,Alexander Perdomo-Pantoja,S J Burris,Kendall Free,Timothy F Witham,Ryan C Riddle,Warren L Grayson

DOI: https://doi.org/10.1016/j.biomaterials.2021.121318

IF: 14

Biomaterials

Abstract:Low oxygen (O2) diffusion into large tissue engineered scaffolds hinders the therapeutic efficacy of transplanted cells. To overcome this, we previously studied hollow, hyperbarically-loaded microtanks (μtanks) to serve as O2 reservoirs. To adapt these for bone regeneration, we fabricated biodegradable μtanks from polyvinyl alcohol and poly (lactic-co-glycolic acid) and embedded them to form 3D-printed, porous poly-ε-caprolactone (PCL)-μtank scaffolds. PCL-μtank scaffolds were loaded with pure O2 at 300-500 psi. When placed at atmospheric pressures, the scaffolds released O2 over a period of up to 8 h. We confirmed the inhibitory effects of hypoxia on the osteogenic differentiation of human adipose-derived stem cells (hASCs and we validated that μtank-mediated transient hyperoxia had no toxic impacts on hASCs, possibly due to upregulation of endogenous antioxidant regulator genes. We assessed bone regeneration in vivo by implanting O2-loaded, hASC-seeded, PCL-μtank scaffolds into murine calvarial defects (4 mm diameters × 0.6 mm height) and subcutaneously (4 mm diameter × 8 mm height). In both cases we observed increased deposition of extracellular matrix in the O2 delivery group along with greater osteopontin coverages and higher mineral deposition. This study provides evidence that even short-term O2 delivery from PCL-μtank scaffolds may enhance hASC-mediated bone tissue regeneration.
Oxygen-generating biomaterials for cardiovascular engineering: unveiling future discoveries

Masoud Mozafari,Mohammad E Barbati

DOI: https://doi.org/10.1016/j.drudis.2024.104135

Abstract:Oxygen-generating biomaterials are emerging as a groundbreaking solution for transforming cardiovascular engineering. These biomaterials generate and release oxygen within various biomedical applications, marking a new frontier in healthcare. Most cardiovascular treatments face a significant challenge, ensuring a consistent oxygen supply to nurture engineered tissues or even implanted devices. Traditional methods relying on passive oxygen diffusion often fall short, hindering functional cardiovascular tissue development. Oxygen-generating biomaterials, incorporating agents like calcium peroxide, provide a controlled oxygen source to the surrounding cells. This innovation potentially enhances cell viability, stimulates growth and boosts metabolic activity crucial for tissue health. Applications include repairing cardiac and vascular tissues, disease modeling, drug testing and personalized medicine, promising tailored treatments. Challenges like material toxicity and oxygen release control need consideration. As research progresses, the use of these innovative biomaterials in clinical translation could reshape cardiovascular healthcare, revolutionizing patient outcomes in heart disease treatment.
Axillary surgery: clinical judgment required.

I. Henderson

DOI: https://doi.org/10.1200/JCO.2005.03.6178

IF: 45.3

2006-01-20

Journal of Clinical Oncology

Abstract:The Halsted radical mastectomy included an en bloc resection of axillary contents. Now, more than a century later, there is little controversy about the use of breast-conserving surgical treatments in place of mastectomy, while the routine use of axillary dissection, or at least axillary sampling, has persisted despite the fact that it is the greatest source of morbidity from breast surgery. Is it time to abandon this procedure all together, at least in some patients? Halsted and his successors removed and/or irradiated lymph nodes because they thought that breast cancer always spreads regionally before metastasizing distantly, and that all regional disease had to be removed to improve survival. The National Surgical Adjuvant Breast and Bowel Project (NSABP) demonstrated in trial B04 that this is not the case. 1 One thousand seventy-nine patients without clinical evidence of axillary adenopathy were randomly assigned to simple mastectomy, a radical mastectomy with lymph node dissection, or simple mastectomy with radiation therapy to the chest wall and axilla. Sixty-eight (19%) of the patients randomly assigned to receive no surgery or radiotherapy to the axilla eventually developed positive axillary nodes. This was about half of the rate expected from the incidence of positive nodes in the radical mastectomy arm of the study, and proved that disease left behind can be kept in check or eradicated by the body’s own defense mechanisms. It was possible to remove the axillary recurrence in all but one of the 68 patients, thus removing the argument that axillary recurrences cannot be managed surgically. Most importantly, with 25 years of follow-up, no significant survival differences have emerged. There have been no randomized trials of similar or larger size addressing the role of axillary surgery without axillary radiotherapy subsequent to NSABP B04. In this issue of the Journal of Clinical Oncology, the International Breast Cancer Study Group (IBCSG) 2 reports the result of a trial in which older patients (defined as those 60 years of age) who were to be treated with tamoxifen regardless of nodal status were randomly assigned to receive clearance of the axillary lymph nodes or no surgical intervention in the axilla after either mastectomy or lumpectomy. Among those randomly assigned to axillary clearance, 28% were node-positive. Radiotherapy was not recommended for patients treated with mastectomy; 60% of those treated with breast-conserving therapy (33% of all patients in the study) had radiotherapy. There was significantly more restriction in arm movement and arm pain during the first few months after treatment among those randomly assigned to axillary clearance, but these differences were small and not significant after longer followup, and there were no differences in overall quality of life parameters. There were no differences in disease-free or overall survival, but there were only 473 patients in the study and the median follow-up was just 6.6 years. This study was originally designed to be much larger, but because of poor accrual the study goals were amended to focus on quality-of-life issues. It seems plausible that the poor accrual reflects a lack of uncertainty by the patients and physicians involved in this trial about the value of axillary node dissection in this patient population. Because of the small size of this study, champions of axillary
Injectable, oxygen-releasing, thermosensitive hydrogel promotes vascularized bone formation with prolonged oxygen delivery and improved osteoinductivity

Yixin Xu,Shaowei Zheng,Zinan Tang,Qiang Zhong,Rong Chen,Pinkai Wang,Jinlang Fu,Jiajun Xie,Yanhong Ning,Mingyuan Lei,Ding Wang,Huaming Mai,Hao Li,Chunhan Sun,Zhanjun Shi,Hao Cheng,Zhe Shi

DOI: https://doi.org/10.1016/j.mtbio.2024.101267

IF: 8.2

2024-10-02

Materials Today Bio

Abstract:The failure or delay in healing of critical bone defects is primarily due to early local anoxic conditions and reduced osteogenic activity. In this research, we integrated calcium peroxide (CPO) embedded polycaprolactone (PCL) microspheres and osteoinductive nanoparticles (Hydroxyapatite/Laponite) into a thermosensitive hydrogel (Pluronic F127), thereby formulating an injectable oxygen-releasing osteogenic thermosensitive hydrogel. Notably, the oxygen-releasing microspheres (ORMs) within the composite hydrogel provide stable oxygen release for up to 21 days, ensuring the survival, migration, and bioactivity of both mesenchymal stem cells and endothelial cells under anoxic conditions. Additionally, the composite hydrogel significantly augments the osteogenic potential of bone marrow mesenchymal stem cells by providing a biomimetic microenvironment with the incorporation of nano-hydroxyapatite/laponite. Ultimately, the injectable composite hydrogel successfully stimulated bone regeneration within a cranial defect in a rat model after 8 weeks, with enhanced vascularization and bone quality. The engineered hydrogel provides a minimally invasive approach to stimulate bone regeneration with a sustained oxygen supply and osteogenic microenvironment provision, underlining its potential for treating critical bone defects.

engineering, biomedical,materials science, biomaterials
Modular Prodrug-Engineered Oxygen Nano-Tank With Outstanding Nanoassembly Performance, High Oxygen Loading, and Closed-Loop Tumor Hypoxia Relief

Fujun Yang,Shumeng Li,Qingyu Ji,Hongyuan Zhang,Mingyang Zhou,Yuequan Wang,Shenwu Zhang,Jin Sun,Zhonggui He,Cong Luo

DOI: https://doi.org/10.1002/advs.202405583

Abstract:The clinical translation of tumor hypoxia intervention modalities still falls short of expectation, restricted by poor biocompatibility of oxygen-carrying materials, unsatisfactory oxygen loading performance, and abnormally high cellular oxygen consumption-caused insufficient hypoxia relief. Herein, a carrier-free oxygen nano-tank based on modular fluorination prodrug design and co-assembly nanotechnology is elaborately exploited, which is facilely fabricated through the molecular nanoassembly of a fluorinated prodrug (FSSP) of pyropheophorbide a (PPa) and an oxygen consumption inhibitor (atovaquone, ATO). The nano-tank adeptly achieves sufficient oxygen enrichment while simultaneously suppressing oxygen consumption within tumors for complete tumor hypoxia alleviation. Significant, the fluorination module in FSSP not only confers favorable co-assemblage of FSSP and ATO, but also empowers the nanoassembly to readily carry oxygen. As expected, it displays excellent oxygen carrying capacity, favorable pharmacokinetics, on-demand laser-triggerable ATO release, closed-loop tumor hypoxia relief, and significant enhancement to PPa-mediated PDT in vitro and in vivo. This study provides a novel nanotherapeutic paradigm for tumor hypoxia intervention-enhanced cancer therapy.
Dual roles of photosynthetic hydrogel with sustained oxygen generation in promoting cell survival and eradicating anaerobic infection

Jun Kang,Ye Liang,Junqing Liu,Mingxin Hu,Shulan Lin,Jialin Zhong,Chaogang Wang,Qinglu Zeng,Chengfei Zhang

DOI: https://doi.org/10.1016/j.mtbio.2024.101197

2024-08-10

Abstract:Tissue engineering offers a promising alternative for oral and maxillofacial tissue defect rehabilitation; however, cells within a sizeable engineered tissue construct after transplantation inevitably face prolonged and severe hypoxic conditions, which may compromise the survivability of the transplanted cells and arouse the concern of anaerobic infection. Microalgae, which can convert carbon dioxide and water into oxygen and glucose through photosynthesis, have been studied as a source of oxygen supply for several biomedical applications, but their promise in orofacial tissue regeneration remains unexplored. Here, we demonstrated that through photosynthetic oxygenation, Chlamydomonas reinhardtii (C. reinhardtii) supported dental pulp stem cell (DPSC) energy production and survival under hypoxia. We developed a multifunctional photosynthetic hydrogel by embedding DPSCs and C. reinhardtii encapsulated alginate microspheres (CAMs) within gelatin methacryloyl hydrogel (GelMA) (CAMs@GelMA). This CAMs@GelMA hydrogel can generate a sustainable and sufficient oxygen supply, reverse intracellular hypoxic status, and enhance the metabolic activity and viability of DPSCs. Furthermore, the CAMs@GelMA hydrogel exhibited selective antibacterial activity against oral anaerobes and remarkable antibiofilm effects on multispecies biofilms by disrupting the hypoxic microenvironment and increasing reactive oxygen species generation. Our work presents an innovative photosynthetic strategy for oral tissue engineering and opens new avenues for addressing other hypoxia-related challenges.
Catalase-Loaded Silica Nanoparticles Formulated via Direct Surface Modification as Potential Oxygen Generators for Hypoxia Relief

Annie Y Heble,Julien Santelli,Amanda M Armstrong,Robert F Mattrey,Jacques Lux

DOI: https://doi.org/10.1021/acsami.0c19633

2021-02-10

Abstract:Enzymes are biological catalysts that have many potential industrial and biomedical applications. However, the widespread use of enzymes in the industry has been limited by their instability and poor recovery. In biomedical applications, systemic administration of enzymes has faced two main challenges: limited bioactivity mostly due to rapid degradation by proteases and immunogenic activity, since most enzymes are from nonhuman sources. Herein, we propose a robust enzyme-encapsulation strategy to mitigate these limitations. Catalase (CAT) was encapsulated in nanoporous silica nanoparticles (CAT-SiNPs) by first chemically modifying the enzyme surface with a silica precursor, followed by silica growth and finally poly(ethylene glycol) (PEG) conjugation. The formulation was carried out in mild aqueous conditions and yielded nanoparticles (NPs) with a mean diameter of 230 ± 10 nm and a concentration of 1.3 ± 0.8 × 1012 NPs/mL. CAT-SiNPs demonstrated high enzyme activity, optimal protection from proteolysis by proteinase K and trypsin, and excellent stability over time. In addition, a new electrochemical assay was developed to measure CAT activity in a rapid, simple, and accurate manner without interference from chromophore usually present in biological samples. Concentrations of 2.5 × 1010 to 80 × 1010 CAT-SiNPs/mL not only proved to be nontoxic in cell cultures using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay but also conferred cell protection when cells were exposed to 1 mM hydrogen peroxide (H2O2). Finally, the ability of CAT-SiNPs to release oxygen (O2) when exposed to H2O2 was demonstrated in vivo using a rat model. Following the direct injection of CAT-SiNPs in the left kidney, partial pressure of oxygen (pO2) increased by more than 30 mmHg compared to the contralateral control kidney during the systemic infusion of safe levels of H2O2. This pilot study highlights the potential of CAT-SiNPs to generate O2 to relieve hypoxia in tissues and potentially sensitize tumors against radiation therapy.
Macromolecular crowding meets oxygen tension in human mesenchymal stem cell culture - A step closer to physiologically relevant in vitro organogenesis

Daniela Cigognini,Diana Gaspar,Pramod Kumar,Abhigyan Satyam,Senthilkumar Alagesan,Clara Sanz-Nogués,Matthew Griffin,Timothy O’Brien,Abhay Pandit,Dimitrios I. Zeugolis

DOI: https://doi.org/10.1038/srep30746

IF: 4.6

2016-08-01

Scientific Reports

Abstract:Modular tissue engineering is based on the cells’ innate ability to create bottom-up supramolecular assemblies with efficiency and efficacy still unmatched by man-made devices. Although the regenerative potential of such tissue substitutes has been documented in preclinical and clinical setting, the prolonged culture time required to develop an implantable device is associated with phenotypic drift and/or cell senescence. Herein, we demonstrate that macromolecular crowding significantly enhances extracellular matrix deposition in human bone marrow mesenchymal stem cell culture at both 20% and 2% oxygen tension. Although hypoxia inducible factor - 1α was activated at 2% oxygen tension, increased extracellular matrix synthesis was not observed. The expression of surface markers and transcription factors was not affected as a function of oxygen tension and macromolecular crowding. The multilineage potential was also maintained, albeit adipogenic differentiation was significantly reduced in low oxygen tension cultures, chondrogenic differentiation was significantly increased in macromolecularly crowded cultures and osteogenic differentiation was not affected as a function of oxygen tension and macromolecular crowding. Collectively, these data pave the way for the development of bottom-up tissue equivalents based on physiologically relevant developmental processes.

multidisciplinary sciences
Hydrogel injection molded complex macroencapsulation device geometry improves long-term cell therapy viability and function in the rat omentum transplant site

Amy E Emerson,Quincy Lyons,Matthew W. Becker,Keven Sepulveda,Shivani C. Hiremath,Sarah R. Brady,Jessica D Weaver

DOI: https://doi.org/10.1101/2024.08.11.607495

2024-08-12

Abstract:Insulin-secreting allogeneic cell therapies are a promising treatment for type 1 diabetes, with the potential to eliminate hypoglycemia and long-term complications of the disease. However, chronic systemic immunosuppression is necessary to prevent graft rejection, and the acute risks associated with immunosuppression limit the number of patients who can be treated with allogeneic cell therapies. Islet macroencapsulation in a hydrogel biomaterial is one proposed method to reduce or eliminate immune suppression; however, macroencapsulation devices suffer from poor oxygen transport and limited efficacy as they scale to large animal model preclinical studies and clinical trials. Hydrogel geometric device designs that optimize nutrient transport combined with methods to promote localized vasculogenesis may improve in vivo macroencapsulated cell viability and function. Here, we demonstrate with finite element modeling that a high surface area-to-volume ratio spiral geometry can increase macroencapsulated islet viability and function relative to a traditional cylindrical design, and we validate these observations in vitro under normoxic and physiological oxygen conditions. Finally, we evaluate macroencapsulated syngeneic islet survival and function in vivo in a diabetic rat omentum transplant model, and demonstrate that high surface area-to-volume hydrogel device designs improved macroencapsulated syngeneic islet function relative to traditional device designs.

Bioengineering

Health in countries torn by conflict: lessons from Sarajevo

Preliminary report on the Mount Sinai Hospital Inflammatory Bowel Disease Genetics Project

Oxygen-Generating Scaffolds: One Step Closer to the Clinical Translation of Tissue Engineered Products

Computer-based ophthalmotropes.

pO2 reporter composite hydrogel macroencapsulation devices for magnetic resonance imaging oxygen quantification

Oxygen-Enriched Osteoinductive Nanoerythrocytes Augment Cell Survival and Osteogenic Differentiation for Bone Regeneration

Astringent Mouthfeel as a Consequence of Lubrication Failure.

Plastic surgery at the turn of the century: an opportunity for self-assessment.

Microfluidic strategies for engineering oxygen-releasing biomaterials

Implantable Multifunctional Micro‐Oxygen Reservoir System for Promoting Vascular‐Osteogenesis via Remodeling Regenerative Microenvironment

Oxygenating respiratoid biosystem for therapeutic cell transplantation

Fabrication of oxygen-releasing dextran microgels by droplet-based microfluidic method

3D-printed oxygen-releasing scaffolds improve bone regeneration in mice

Oxygen-generating biomaterials for cardiovascular engineering: unveiling future discoveries

Axillary surgery: clinical judgment required.

Injectable, oxygen-releasing, thermosensitive hydrogel promotes vascularized bone formation with prolonged oxygen delivery and improved osteoinductivity

Modular Prodrug-Engineered Oxygen Nano-Tank With Outstanding Nanoassembly Performance, High Oxygen Loading, and Closed-Loop Tumor Hypoxia Relief

Dual roles of photosynthetic hydrogel with sustained oxygen generation in promoting cell survival and eradicating anaerobic infection

Catalase-Loaded Silica Nanoparticles Formulated via Direct Surface Modification as Potential Oxygen Generators for Hypoxia Relief

Macromolecular crowding meets oxygen tension in human mesenchymal stem cell culture - A step closer to physiologically relevant in vitro organogenesis

Hydrogel injection molded complex macroencapsulation device geometry improves long-term cell therapy viability and function in the rat omentum transplant site